|
⚲
|
| Keyboard |
| Lindsay Rayle | |
|---|---|
| Firm | |
| Address | c/o Proniras Corporation 2815 Eastlake Avenue East, Suite 300 Seattle, WA 98102 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Proniras Corp | 021-501120 | Executive Officer | 6.9 M of 12.2 M |
||
| Petra Pharma Corp | 021-321233 | Promoter | 27.5 M of 27.5 M |
||
| Proniras Corp | 021-294038 | Executive Officer | 4.3 M of 4.3 M |
||
| Rodeo Therapeutics Corp | 021-291967 | Executive Officer | 5.4 M of 5.9 M |
||
| Apogen Biotechnologies Inc | 021-275911 | Executive Officer | 7.6 M of 7.6 M |
||
| Petra Pharma Corp | 021-254662 | Promoter | 31.2 M of 48.2 M |
||
| LODO Therapeutics Corp | 021-254438 | Executive Officer | 19.9 M of 19.9 M |
||
| Oncofactor Corp | 021-202194 | Executive Officer | 1.0 M of 6.0 M |
||
| Acylin Therapeutics Inc | 021-179179 | Executive Officer | 2.0 M of 2.0 M |
||
| Groove Biopharma Corp | 021-170387 | Executive Officer | 4.5 M of 6.0 M |
||
| Oncofactor Corp | 021-160076 | Executive Officer | 2.1 M of 5.1 M |
||
| Mirina Corp | 021-141242 | Executive Officer | 3.9 M | ||
| XORI Corp | 021-131262 | Executive Officer | 2.1 M of 4.5 M |
||